| Company Name: |
TOSUN PHARM |
| Tel: |
020-66392521-118 18922260391 |
| Email: |
3004261881@qq.com |
|
| | Pemetrexed disodium Ketone impurity Basic information |
| Product Name: | Pemetrexed disodium Ketone impurity | | Synonyms: | Pemetrexed disodium Ketone impurity;L-Glutamic acid, N-[4-[2-(2-amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-;6-Ketopemetrexed;Ketopemetrexed | | CAS: | 1644287-27-3 | | MF: | C20H21N5O7 | | MW: | 443.41 | | EINECS: | | | Product Categories: | | | Mol File: | 1644287-27-3.mol |  |
| | Pemetrexed disodium Ketone impurity Chemical Properties |
| density | 1.67±0.1 g/cm3(Predicted) | | pka | 3.59±0.10(Predicted) | | Major Application | pharmaceutical |
| | Pemetrexed disodium Ketone impurity Usage And Synthesis |
| Uses | N-[4-[2-(2-Amino-4,5,6,7-tetrahydro-4,6-dioxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl] L-Glutamic Acid is a metabolite of Pemetrexed Disodium (P219500), an antitumor agent. |
| | Pemetrexed disodium Ketone impurity Preparation Products And Raw materials |
|